Xenon Pharmaceuticals Files 8-K
Ticker: XENE · Form: 8-K · Filed: Mar 17, 2025 · CIK: 1582313
| Field | Detail |
|---|---|
| Company | Xenon Pharmaceuticals Inc. (XENE) |
| Form Type | 8-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Pharmaceuticals
TL;DR
Xenon Pharma filed an 8-K on 3/17 for a 3/14 event - check for updates.
AI Summary
Xenon Pharmaceuticals Inc. filed an 8-K on March 17, 2025, reporting an event that occurred on March 14, 2025. The filing pertains to "Other Events" and "Financial Statements and Exhibits." Specific details regarding the nature of these events or exhibits were not provided in the excerpt.
Why It Matters
This filing indicates Xenon Pharmaceuticals Inc. is making a material disclosure to the SEC, which could contain important updates for investors.
Risk Assessment
Risk Level: low — The filing is a standard disclosure form (8-K) without immediate indication of negative financial or operational news.
Key Numbers
- 001-36687 — SEC File Number (Identifies the company's filings with the SEC)
- 98-0661854 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Xenon Pharmaceuticals Inc. (company) — Registrant
- March 14, 2025 (date) — Earliest event date
- March 17, 2025 (date) — Filing date
- 3650 Gilmore Way Burnaby (location) — Principal Executive Offices
FAQ
What specific event occurred on March 14, 2025, that necessitated this 8-K filing?
The provided excerpt does not specify the exact nature of the event reported under 'Other Events'.
What financial statements or exhibits are included with this filing?
The excerpt indicates 'Financial Statements and Exhibits' are part of the filing, but does not list their specific contents.
What is Xenon Pharmaceuticals Inc.'s primary business sector?
Xenon Pharmaceuticals Inc. is in the 'PHARMACEUTICAL PREPARATIONS' sector, SIC code 2834.
Where are Xenon Pharmaceuticals Inc.'s principal executive offices located?
The principal executive offices are located at 3650 Gilmore Way, Burnaby, British Columbia, Canada.
What is the company's fiscal year end?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 17, 2025 regarding Xenon Pharmaceuticals Inc. (XENE).